News

Innovative Injection Molding Technology Set to Impress at Hannover Messe

Innovative Injection Molding Technology Set to Impress at Hannover Messe

Innovative Injection Molding Technology at Hannover Messe

Global Leaders in Manufacturing Spotlight Canadian Partnership and Demonstrate Altanium Mold Controller Technology

HARTING, the leading name in connectivity for industrial environments, and Husky Technologies, a prominent player in injection molding technology, are excited to showcase their latest innovations at Hannover Messe. This event promises to reveal the Altanium Neo Mold Controller, an advanced device that integrates HARTING's reliable cables and connectors, streamlining the manufacturing process.

This partnership, which highlights Canada's significant role in the event, reflects the tremendous potential that arises from collaboration in the manufacturing sector. For over 15 years, Husky and HARTING have worked side by side to enhance the Altanium Mold Controller product line, delivering intelligent solutions that ease injection molding operations.

Key Features of the Altanium Mold Controller

One of the standout aspects of the Altanium Mold Controller is its impressive set of features that facilitate more efficient production.

  • Single-point operation for ease of use
  • Advanced control of hot runner temperature zones for better precision
  • Mold servo control that ensures accuracy in movements
  • Valve gate sequencing that enhances the molding process
  • Smart control features aimed at effective data collection and repeatability
  • Active Reasoning Technology (Art 2.0), offering a remarkable 42% reduction in heat-up times and a 30% cut in energy consumption

The controller's integration of HARTING connectors, electrical inserts, and full cable assemblies ensures seamless communication throughout the process, which maximizes efficiency and minimizes energy loss. HARTING’s Han® range is crucial in addressing the connectivity needs within the injection molding industry.

Commitment to Innovation and Sustainability

According to Brad Selleck, CEO of Husky Technologies, "HARTING and Husky are dedicated to delivering state-of-the-art and sustainable technology. Our enduring partnership showcases how collaborative innovations can lead to exceptional outcomes. The greatest breakthroughs often arise from teamwork that unites distinct fields of expertise.”

HARTING will take center stage at Hall 11, Stand C43, where they will embrace the theme of Connecting the All Electric Society. Highlights of their booth will include:

  • A live demonstration of Husky's Altanium Mold Controller along with materials showcasing its capabilities
  • Scalable connector and cable solutions tailored for the hydrogen and energy storage sectors
  • Cutting-edge developments in eMobility, presenting eco-friendly solutions compliant with both European and American standards
  • A demonstration of a 'Robotic Automation Line' with the latest technology for power and data transmission
  • The AI-powered Han configurator, illustrating generative AI in the configuration process from cable to PCB

“The partnership between Husky and HARTING symbolizes our commitment to a greener industry through efficient products and processes that conserve resources while we move towards an all-electric future,” said Jon DeSouza, CEO of HARTING Americas. His satisfaction with the combined expertise of both firms reinforces their objective to lead in innovation.

Visit Us at Hannover Messe

If you're interested in learning more about the collaboration between Husky and HARTING, experience a live demo of the Altanium Mold Controller, and explore cutting-edge technologies for manufacturers, stop by HARTING's exhibit at Hall 11, Stand C43.

About Husky Technologies

Since its inception in 1953, Husky Technologies™ has been at the forefront of manufacturing technologies that fulfill essential global needs. Operating from more than 40 locations worldwide and serving clients in over 140 countries, Husky is steadfastly focused on using sustainably sourced materials and medical-grade polymers. This commitment positions Husky as a leader in enabling a circular economy.

About HARTING Americas

HARTING is recognized globally as a standard-bearer in connectivity solutions designed for industrial applications. With a legacy grounded in quality and service, HARTING combines local manufacturing capabilities with extensive engineering expertise. Their dedication to connectivity enhances efficiency and sustainability, empowering businesses to innovate for the future.

Frequently Asked Questions

What technologies are Husky and HARTING presenting at Hannover Messe?

They are showcasing the Altanium Mold Controller alongside various connectivity solutions aimed at the industrial sector.

How long have Husky and HARTING been collaborating?

The two companies have partnered for over 15 years to advance injection molding technology.

What is the significance of the Altanium Mold Controller?

This controller enhances injection molding production with improved features for precision and control, ultimately increasing efficiency.

Where can attendees find HARTING at Hannover Messe?

HARTING will be located at Hall 11, Stand C43 during the event.

What is the theme of HARTING's booth?

The theme is 'Connecting the All Electric Society,' focusing on innovations that promote sustainability in industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading